Company intelligence / Profile preview

ABC Investment

Ivrea, Piedmont, Italyabcinvestmentservices.com ↗

Ownership: Private
Development stage: Other

Overview

ABC Farmaceutici manufactures and commercializes a wide range of branded pharmaceuticals, generics, medical devices for GI disorders and dermatology, nutraceuticals/supplements, cosmetics for hygiene/dermatology treatments. It specializes in bile acid APIs—being the leading global manufacturer of ursodeoxycholic acid—and offers full CDMO services under EU GMP compliance. The company was acquired by ICE Pharma in December 2023.

Therapeutic areas: GastroenterologyDermatology
Modalities: Small moleculeActive pharmaceutical ingredient (API)Medical deviceNutraceuticalCosmetic product
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on ABC Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABC Investment.

Explore the full profile